Gene therapy of the rheumatic diseases: 1998 to 2008

Arthritis Research and Therapy

Volumn 11, Issue 1, 2009, Pages

  Evans, Christopher H ^a   Ghivizzani, Steven C ^b   Robbins, Paul D ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; COMPLEMENTARY DNA; COMPLEMENTARY RNA; DNA VACCINE; ETANERCEPT; HERPES SIMPLEX VIRUS THYMIDINE KINASE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; PARVOVIRUS VECTOR; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RETROVIRUS VECTOR; THYMIDINE KINASE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ANTIGEN PRESENTING CELL; CARTILAGE REGENERATION; CLINICAL TRIAL; DNA IMMUNIZATION; DNA TRANSFER; FIBROBLAST; GENE EXPRESSION; GENE THERAPY; GENETIC ENGINEERING; GOUT; HISTOPLASMOSIS; HUMAN; IMMUNOGENICITY; KNEE; LOCAL THERAPY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; OSTEOARTHRITIS; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SALIVARY GLAND; SEROTYPE; SJOEGREN SYNDROME; SYNOVIAL FIBROBLAST; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC THERAPY; T LYMPHOCYTE; TISSUE REGENERATION; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT; ANIMAL; GENETICS; HISTORY;

ANIMALS; CLINICAL TRIALS AS TOPIC; GENE THERAPY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; RHEUMATIC DISEASES;

EID: 60649108789     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2563     Document Type: Review

References (106)

1. Evans CH Rediske JJ Abramson SB Robbins PD Joint efforts: Tackling arthritis using gene therapy. First International Meeting on the Gene Therapy of Arthritis and Related Disorders. Bethesda, MD, USA, 2-3 December 1998 Molecular Medicine Today 1999, 5:148-151 10.1016/ S1357-4310(99)01452-5 10203745
2. Raper SE Chirmule N Lee FS Wivel NA Bagg A Gao GP Wilson JM Batshaw ML Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer Mol Genet Metab 2003 80 148-158 10.1016/j.ymgme.2003.08.016 14567964
3. Wilson JM Gendicine: The first commercial gene therapy product Hum Gene Ther 2005, 16:1014-1015 10.1089/hum.2005.16.1014 16149899
4. Cavazzana-Calvo M Hacein-Bey S de Saint Basile G Gross F Yvon E Nusbaum P Selz F Hue C Certain S Casanova JL Bousso P Deist FL Fischer A Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease Science 2000, 288:669-672 10.1126/science.288.5466.669 10784449
5. Gaspar HB Bjorkegren E Parsley K Gilmour KC King D Sinclair J Zhang F Giannakopoulos A Adams S Fairbanks LD Gaspar J Henderson L Xu-Bayford JH Davies EG Veys PA Kinnon C Thrasher AJ Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning Mol Ther 2006, 14:505-513 10.1016/j.ymthe.2006.06.007 16905365
6. Ott MG Schmidt M Schwarzwaelder K Stein S Siler U Koehl U Glimm H Kuhlcke K Schilz A Kunkel H Naundorf S Brinkmann A Deichmann A Fischer M Ball C Pilz I Dunbar C Du Y Jenkins NA Copeland NG Lüthi U Hassan M Thrasher AJ Hoelzer D von Kalle C Seger R Grez M Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1 Nat Med 2006, 12:401-409 10.1038/nm1393 16582916
7. Bainbridge JW Smith AJ Barker SS Robbie S Henderson R Balaggan K Viswanathan A Holder GE Stockman A Tyler N Petersen-Jones S Bhattacharya SS Thrasher AJ Fitzke FW Carter BJ Rubin GS Moore AT Ali RR Effect of gene therapy on visual function in Leber's congenital amaurosis N Engl J Med 2008, 358:2231-2239 10.1056/NEJMoa0802268 18441371
8. Maguire AM Simonelli F Pierce EA Pugh EN Jr Mingozzi F Bennicelli J Banfi S Marshall KA Testa F Surace EM Rossi S Lyubarsky A Arruda VR Konkle B Stone E Sun J Jacobs J Dell'Osso L Hertle R Ma JX Redmond TM Zhu X Hauck B Zelenaia O Shindler KS Maguire MG Wright JF Volpe NJ McDonnell JW Auricchio A High KA Bennett J Safety and efficacy of gene transfer for Leber's congenital amaurosis N Engl J Med 2008, 358:2240-2248 10.1056/NEJMoa0802315 18441370
9. Evans CH Ghivizzani SC Gouze E Rediske JJ Schwarz EM Robbins PD The 3rd International Meeting on Gene Therapy in Rheumatology and Orthopaedics Arthritis Res Ther 2005, 7:273-278 1297596 16277703 10.1186/ar1853
10. Robbins PD Evans CH Jorgensen C Gene therapy moves forward - the second international meeting on gene and cell therapies of arthritis and related disorders, 17-18 May 2001, Montpellier, France Arthritis Res Ther 2001, 3:289-292 1297596 16277703
11. Hacein-Bey-Abina S von Kalle C Schmidt M Le Deist F Wulffraat N McIntyre E Radford I Villeval JL Fraser CC Cavazzana-Calvo M Fischer A A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency N Engl J Med 2003, 348:255-256 10.1056/ NEJM200301163480314 12529469
12. Gouze E Pawliuk R Gouze JN Pilapil C Fleet C Palmer GD Evans CH Leboulch P Ghivizzani SC Lentiviral-mediated gene delivery to synovium: Potent intra-articular expression with amplification by inflammation Mol Ther 2003, 7:460-466 10.1016/S1525-0016(03)00024-8 12727108
13. Gouze E Pawliuk R Pilapil C Gouze JN Fleet C Palmer GD Evans CH Leboulch P Ghivizzani SC In vivo gene delivery to synovium by lentiviral vectors Mol Ther 2002, 5:397-404 10.1006/mthe.2002.0562 11945066
14. Imperiale MJ Kochanek S Adenovirus vectors: Biology, design, and production Curr Top Microbiol Immunol 2004, 273:335-357 14674606
15. Toh ML Hong SS Loo van de F Franqueville L Lindholm L Berg van den W Boulanger P Miossec P Enhancement of aden-ovirus-mediated gene delivery to rheumatoid arthritis synoviocytes and synovium by fiber modifications: Role of arginine-glycine-aspartic acid (RGD)- and non-RGD-binding integrins J Immunol 2005, 175:7687-7698 16301679
16. Grieger JC Choi VW Samulski RJ Production and characterization of adeno-associated viral vectors Nat Protoc 2006, 1:1412-1428 10.1038/ nprot.2006.207 17406430
17. McCarty DM Fu H Monahan PE Toulson CE Naik P Samulski RJ Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo Gene Ther 2003, 10:2112-2118 10.1038/sj.gt.3302134 14625565
18. Kay JD Gouze E Oligino TJ Gouze JN Watson RS Levings PP Bush ML Dacanay A Robbins PD Evans CH Ghivizzani SC Intra-articular gene delivery and expression of IL-1Ra mediated by self-complementary adeno-associated virus J Gene Med 2008
19. Wu Z Asokan A Samulski RJ Adeno-associated virus serotypes: Vector toolkit for human gene therapy Mol Ther 2006, 14:316-327 10.1016/ j.ymthe.2006.05.009 16824801
20. Louboutin JP Wang L Wilson JM Gene transfer into skeletal muscle using novel AAV serotypes J Gene Med 2005, 7:442-451 10.1002/jgm.686 15517544
21. Manno CS Pierce GF Arruda VR Glader B Ragni M Rasko JJ Ozelo MC Hoots K Blatt P Konkle B Dake M Kaye R Razavi M Zajko A Zehnder J Rustagi PK Nakai H Chew A Leonard D Wright JF Lessard RR Sommer JM Tigges M Sabatino D Luk A Jiang H Mingozzi F Couto L Ertl HC High KA Kay MA Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response Nat Med 2006, 12:342-347 10.1038/nm1358 16474400
22. Mingozzi F Maus MV Hui DJ Sabatino DE Murphy SL Rasko JE Ragni MV Manno CS Sommer J Jiang H Pierce GF Ertl HC High KA CD8(+) T-cell responses to adeno-associated virus capsid in humans Nat Med 2007, 13:419-422 10.1038/ nm1549 17369837
23. Evans CH Ghivizzani SC Robbins PD Arthritis gene therapy's first death Arthritis Res Ther 2008, 10:110 2483436 18510784 10.1186/ar2411
24. Thomas CE Ehrhardt A Kay MA Progress and problems with the use of viral vectors for gene therapy Nat Rev Genet 2003, 4:346-358 10.1038/nrg1066 12728277
25. Conwell CC Huang L Recent advances in non-viral gene delivery Adv Genet 2005, 53:3-18 16240988
26. Bandara G Mueller GM Galea-Lauri J Tindal MH Georgescu HI Suchanek MK Hung GL Glorioso JC Robbins PD Evans CH Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer Proc Natl Acad Sci USA 1993, 90:10764-10768 47858 8248169 10.1073/pnas.90.22.10764
27. Bandara G Robbins PD Georgescu HI Mueller GM Glorioso JC Evans CH Gene transfer to synoviocytes: Prospects for gene treatment of arthritis DNA Cell Biol 1992, 11:227-231 1567555
28. Evans CH Ghivizzani SC Robbins PD Gene therapy for arthritis: What next? Arthritis Rheum 2006, 54:1714-1729 10.1002/art.21886 16729280
29. Evans CH Robbins PD Ghivizzani SC Herndon JH Kang R Bahnson AB Barranger JA Elders EM Gay S Tomaino MM Wasko MC Watkins SC Whiteside TL Glorioso JC Lotze MT Wright TM Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis Hum Gene Ther 1996, 7:1261-1280 10.1089/hum.1996.7.10-1261 8793551
30. Evans CH Robbins PD Ghivizzani SC Wasko MC Tomaino MM Kang R Muzzonigro TA Vogt M Elder EM Whiteside TL Watkins SC Herndon JH Gene transfer to human joints: Progress toward a gene therapy of arthritis Proc Natl Acad Sci USA 2005, 102:8698-8703 1150836 15939878 10.1073/pnas.0502854102
31. Wehling P Reinecke J Baltzer AA Granrath M Schulitz KP Schultz C Krauspe R Whiteside T Elder E Ghivizzani SC Robbins PD Evans CH Clinical responses to gene therapy in joints of two subjects with rheumatoid arthritis Hum Gene Ther 2008 18986219
32. Sant SM Suarez TM Moalli MR Wu BY Blaivas M Laing TJ Roessler BJ Molecular lysis of synovial lining cells by in vivo herpes simplex virusthymidine kinase gene transfer Hum Gene Ther 1998, 9:2735-2743 10.1089/hum.1998.9.18-2735 9874272
33. Mease PJ Hobbs K Chalmers A El-Gabalawy H Bookman A Keystone E Furst DE Anklesaria P Heald AE Local delivery of a recombinant adeno-associated vector containing a tumor necrosis factor-{alpha} antagonist gene in inflammatory arthritis: A phase 1 dose-escalation safety and tolerability study Ann Rheum Dis 2008
34. Mease P Wei N Fudman E Kivitz A Anklesaria P Heald A Local treatment for inflammatory arthritis: A phase 1/2 clinical study of intra-articular administration of a recombinant adeno-associated vector containing a TNF-a antagonist gene [abstract] Arthritis Rheum 2007, 56(suppl 9):S793
35. Apparailly F Khoury M Vervoordeldonk MJ Adriaansen J Gicquel E Perez N Riviere C Louis-Plence P Noel D Danos O Douar AM Tak PP Jorgensen C Adeno-associated virus pseudotype 5 vector improves gene transfer in arthritic joints Hum Gene Ther 2005, 16:426-434 10.1089/hum.2005.16.426 15871674
36. Adriaansen J Tas SW Klarenbeek PL Bakker AC Apparailly F Firestein GS Jorgensen C Vervoordeldonk MJ Tak PP Enhanced gene transfer to arthritic joints using adeno-associated virus type 5: Implications for intra-articular gene therapy Ann Rheum Dis 2005, 64:1677-1684 1755308 15878906 10.1136/ard.2004.035063
37. Boissier MC Lemeiter D Clavel C Valvason C Laroche L Begue T Bessis N Synoviocyte infection with adeno-associated virus (AAV) is neutralized by human synovial fluid from arthritis patients and depends on AAV serotype Hum Gene Ther 2007, 18:525-535 10.1089/hum.2006.174 17532727
38. Adriaansen J Khoury M de Cortie CJ Fallaux FJ Bigey P Scherman D Gould DJ Chernajovsky Y Apparailly F Jorgensen C Vervoordeldonk MJ Tak PP Reduction of arthritis following intra-articular administration of an adeno-associated virus serotype 5 expressing a disease-inducible TNF-blocking agent Ann Rheum Dis 2007, 66:1143-1150 10.1136/ ard.2006.064519 17363402
39. Adriaansen J Fallaux FJ de Cortie CJ Vervoordeldonk MJ Tak PP Local delivery of beta interferon using an adeno-associated virus type 5 effectively inhibits adjuvant arthritis in rats J Gen Virol 2007, 88:1717-1721 10.1099/vir.0.82603-0 17485531
40. Takahashi H Kato K Miyake K Hirai Y Yoshino S Shimada T Adeno-associated virus vector-mediated anti-angiogenic gene therapy for collagen-induced arthritis in mice Clin Exp Rheumatol 2005, 23:455-461 16095112
41. Tas SW Adriaansen J Hajji N Bakker AC Firestein GS Vervoordeldonk MJ Tak PP Amelioration of arthritis by intraarticular dominant negative Ikk beta gene therapy using adeno-associated virus type 5 Hum Gene Ther 2006, 17:821-832 10.1089/hum.2006.17.821 16942442
42. Ulrich-Vinther M Duch MR Soballe K O'Keefe RJ Schwarz EM Pedersen FS In vivo gene delivery to articular chondrocytes mediated by an adeno-associated virus vector J Orthop Res 2004, 22:726-734 10.1016/ j.orthres.2003.12.003 15183427
43. Jennings K Miyamae T Traister R Marinov A Katakura S Sowders D Trapnell B Wilson JM Gao G Hirsch R Proteasome inhibition enhances AAV-mediated transgene expression in human synoviocytes in vitro and in vivo Mol Ther 2005, 11:600-607 10.1016/j.ymthe.2004.10.020 15771962
44. Zhong L Li B Mah CS Govindasamy L Agbandje-McKenna M Cooper M Herzog RW Zolotukhin I Warrington KH Jr Weigel-Van Aken KA Hobbs JA Zolotukhin S Muzyczka N Srivastava A Next generation of adeno-associated virus 2 vectors: Point mutations in tyrosines lead to high-efficiency transduction at lower doses Proc Natl Acad Sci USA 2008, 105:7827-7832 2402387 18511559 10.1073/pnas.0802866105
45. Traister RS Fabre S Wang Z Xiao X Hirsch R Inflammatory cytokine regulation of transgene expression in human fibroblast-like synoviocytes infected with adeno-associated virus Arthritis Rheum 2006, 54:2119-2126 10.1002/art.21940 16802345
46. Pan RY Chen SL Xiao X Liu DW Peng HJ Tsao YP Therapy and prevention of arthritis by recombinant adeno-associated virus vector with delivery of interleukin-1 receptor antagonist Arthritis Rheum 2000, 43:289-297 10.1002/1529-0131(200002)43:2<289::AID-ANR8>3.0.CO;2-H 10693868
47. Pan RY Xiao X Chen SL Li J Lin LC Wang HJ Tsao YP Disease-inducible transgene expression from a recombinant adeno-associated virus vector in a rat arthritis model J Virol 1999, 73:3410-3417 104105 10074195
48. Gouze E Gouze JN Palmer GD Pilapil C Evans CH Ghivizzani SC Transgene persistence and cell turnover in the diarthrodial joint: Implications for gene therapy of chronic joint diseases Mol Ther 2007, 15:1114-1120 17440444
49. Miagkov AV Varley AW Munford RS Makarov SS Endogenous regulation of a therapeutic transgene restores homeostasis in arthritic joints J Clin Invest 2002, 109:1223-1229 150962 11994411
50. Loo van de FA de Hooge AS Smeets RL Bakker AC Bennink MB Arntz OJ Joosten LA van Beuningen HM Kraan van der PK Varley AW Berg van den WB An inflammation-inducible adenoviral expression system for local treatment of the arthritic joint Gene Ther 2004, 11:581-590 10.1038/ sj.gt.3302182 14973543
51. Apparailly F Millet V Noel D Jacquet C Sany J Jorgensen C Tetracycline-inducible interleukin-10 gene transfer mediated by an adeno-associated virus: Application to experimental arthritis Hum Gene Ther 2002, 13:1179-1188 10.1089/104303402320138961 12133271
52. Gould DJ Berenstein M Dreja H Ledda F Podhajcer OL Chernajovsky Y A novel doxycycline inducible autoregulatory plasmid which displays 'on'/ 'off' regulation suited to gene therapy applications Gene Ther 2000, 7:2061-2070 10.1038/sj.gt.3301354 11223986
53. Zhang HG Hyde K Page GP Brand JP Zhou J Yu S Allison DB Hsu HC Mountz JD Novel tumor necrosis factor alpha-regulated genes in rheumatoid arthritis Arthritis Rheum 2004, 50:420-431 10.1002/art.20037 14872484
54. Tomita T Takeuchi E Tomita N Morishita R Kaneko M Yamamoto K Nakase T Seki H Kato K Kaneda Y Ochi T Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucheotides as a gene therapy Arthritis Rheum 1999, 42:2532-2542 10.1002/ 1529-0131(199912)42:12<2532::AID-ANR5>3.0.CO;2-2 10615998
55. Dreja H Annenkov A Chernajovsky Y Soluble complement receptor 1 (CD35) delivered by retrovirally infected syngeneic cells or by naked DNA injection prevents the progression of collagen-induced arthritis Arthritis Rheum 2000, 43:1698-1709 10.1002/ 1529-0131(200008)43:8<1698::AID-ANR5>3.0.CO;2-8 10943859
56. Fellowes R Etheridge CJ Coade S Cooper RG Stewart L Miller AD Woo P Amelioration of established collagen induced arthritis by systemic IL-10 gene delivery Gene Ther 2000, 7:967-977 10.1038/sj.gt.3301165 10849557
57. Kim JM Jeong JG Ho SH Hahn W Park EJ Kim S Yu SS Lee YW Kim S Protection against collagen-induced arthritis by intramuscular gene therapy with an expression plasmid for the interleukin-1 receptor antagonist Gene Ther 2003, 10:1543-1550 10.1038/sj.gt.3302042 12907945
58. Kageyama Y Koide Y Uchijima M Nagata T Yoshida A Taiki A Miura T Nagafusa T Nagano A Plasmid encoding interleukin-4 in the amelioration of murine collagen-induced arthritis Arthritis Rheum 2004, 50:968-975 10.1002/art.20107 15022341
59. Miyata M Sasajima T Sato H Saito A Saito A Iriswa A Sato Y Kasukawa R Suppression of collagen induced arthritis in mice utilizing plasmid DNA encoding interleukin 10 J Rheumatol 2000, 27:1601-1605 10914840
60. Song XY Gu M Jin WW Klinman DM Wahl SM Plasmid DNA encoding transforming growth factor-beta1 suppresses chronic disease in a streptococcal cell wall-induced arthritis model J Clin Invest 1998, 101:2615-2621 508851 9637694 10.1172/JCI2480
61. Woods AM Thompson SJ Wooley PH Panayi G Klavinskis LS Immune modulation of collagen-induced arthritis by intranasal cytokine gene delivery: A model for the therapy of rheumatoid arthritis Arthritis Rheum 2005, 52:3761-3771 10.1002/art.21473 16329091
62. Quintana FJ Carmi P Mor F Cohen IR Inhibition of adjuvant arthritis by a DNA vaccine encoding human heat shock protein 60 J Immunol 2002, 169:3422-3428 12218165
63. Dalum I Butler DM Jensen MR Hindersson P Steinaa L Waterston AM Grell SN Feldmann M Elsner HI Mouritsen S Therapeutic antibodies elicited by immunization against TNF-alpha Nat Biotechnol 1999, 17:666-669 10.1038/ 10878 10404159
64. McDevitt H Specific antigen vaccination to treat autoimmune disease Proc Natl Acad Sci USA 2004, 101(Suppl 2):14627-14630 521997 15466699 10.1073/ pnas.0405235101
65. Ghivizzani SC Lechman ER Kang R Tio C Kolls J Evans CH Robbins PD Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects Proc Natl Acad Sci USA 1998, 95:4613-4618 22538 9539786 10.1073/pnas.95.8.4613
66. Kim SH Lechman ER Kim S Nash J Oligino TJ Robbins PD Ex vivo gene delivery of IL-1Ra and soluble TNF receptor confers a distal synergistic therapeutic effect in antigen-induced arthritis Mol Ther 2002, 6:591-600 10.1016/S1525-0016(02)90711-2 12409257
67. Whalen JD Thomson AW Lu L Robbins PD Evans CH Viral IL-10 gene transfer inhibits DTH responses to soluble antigens: Evidence for involvement of genetically modified dendritic cells and macrophages Mol Ther 2001, 4:543-550 10.1006/mthe.2001.0492 11735338
68. Kim SH Kim S Evans CH Ghivizzani SC Oligino T Robbins PD Effective treatment of established murine collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express IL-4 J Immunol 2001, 166:3499-3505 11207309
69. Kim SH Kim S Oligino TJ Robbins PD Effective treatment of established mouse collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express FasL Mol Ther 2002, 6:584-590 10.1016/S1525-0016(02)90712-4 12409256
70. Zhan HG Mountz JD Fleck M Zhou T Hsu HC Specific deletion of autoreactive T cells by adenovirus-transfected, Fas ligand-producing antigen-presenting cells Immunol Res 2002, 26:235-246 10.1385/ IR:26:1-3:235 12403361
71. Liu Z Xu X Hsu HC Tousson A Yang PA Wu Q Liu C Yu S Zhang HG Mountz JD CII-DC-AdTRAIL cell gene therapy inhibits infiltration of CII-reactive T cells and CII-induced arthritis J Clin Invest 2003, 112:1332-1341 228459 14597760
72. Terzioglu E Bisgin A Sanlioglu AD Ulker M Yazisiz V Tuzuner S Sanlioglu S Concurrent gene therapy strategies effectively destroy synoviocytes of patients with rheumatoid arthritis Rheumatology (Oxford) 2007, 46:783-789 10.1093/rheumatology/kel448 17309888
73. Tarner IH Slavin AJ McBride J Levicnik A Smith R Nolan GP Contag CH Fathman CG Treatment of autoimmune disease by adoptive cellular gene therapy Ann N Y Acad Sci 2003, 998:512-519 10.1196/annals.1254.067 14592922
74. Slavin AJ Tarner IH Nakajima A Urbanek-Ruiz I McBride J Contag CH Fathman CG Adoptive cellular gene therapy of autoimmune disease Autoimmun Rev 2002, 1:213-219 10.1016/S1568-9972(02)00051-4 12848998
75. Annenkov A Chernajovsky Y Engineering mouse T lymphocytes specific to type II collagen by transduction with a chimeric receptor consisting of a single chain Fv and TCR zeta Gene Ther 2000, 7:714-722 10.1038/ sj.gt.3301149 10800096
76. http://ir.isispharm.com/releasedetail.cfm?ReleaseID=220333
77. Khoury M Escriou V Courties G Galy A Yao R Largeau C Scherman D Jorgensen C Apparailly F Efficient suppression of murine arthritis by combined anticytokine small interfering RNA lipoplexes Arthritis Rheum 2008, 58:2356-2367 10.1002/art.23660 18668557
78. Evans CH Gouze JN Gouze E Robbins PD Ghivizzani SC Osteoarthritis gene therapy Gene Ther 2004, 11:379-389 10.1038/sj.gt.3302196 14724685
79. Pelletier JP Caron JP Evans C Robbins PD Georgescu HI Jovanovic D Fernandes JC Martel-Pelletier J In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy Arthritis Rheum 1997, 40:1012-1019 10.1002/art.1780400604 9182910
80. Fernandes J Tardif G Martel-Pelletier J Lascau-Coman V Dupuis M Moldovan F Sheppard M Krishnan BR Pelletier JP In vivo transfer of interleukin-1 receptor antagonist gene in osteoarthritic rabbit knee joints: prevention of osteoarthritis progression Am J Pathol 1999, 154:1159-1169 1866546 10233854
81. Zhang X Mao Z Yu C Suppression of early experimental osteoarthritis by gene transfer of interleukin-1 receptor antagonist and interleukin-10 J Orthop Res 2004, 22:742-750 10.1016/j.orthres.2003.12.007 15183429
82. Zhang X Yu C Xushi Zhang C Tang T Dai K Direct chitosan-mediated gene delivery to the rabbit knee joints in vitro and in vivo Biochem Biophys Res Commun 2006, 341:202-208 10.1016/j.bbrc.2005.12.171 16413501
83. Frisbie DD Ghivizzani SC Robbins PD Evans CH McIlwraith CW Treatment of experimental equine osteoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonist gene Gene Ther 2002, 9:2-20 10.1038/ sj.gt.3301608 11850718
84. Cucchiarini M Madry H Gene therapy for cartilage defects J Gene Med 2005, 7:1495-1509 10.1002/jgm.824 16142829
85. Lee KH Song SU Hwang TS Yi Y Oh IS Lee JY Choi KB Choi MS Kim SJ Regeneration of hyaline cartilage by cell-mediated gene therapy using transforming growth factor beta 1-producing fibroblasts Hum Gene Ther 2001, 12:1805-1813 10.1089/104303401750476294 11560773
86. Murakami Y Akahoshi T Hayashi I Endo H Hashimoto A Kono S Kondo H Kawai S Inoue M Kitasato H Inhibition of monosodium urate monohydrate crystal-induced acute inflammation by retrovirally transfected prostaglandin D synthase Arthritis Rheum 2003, 48:2931-2941 10.1002/ art.11271 14558100
87. So A De Smedt T Revaz S Tschopp J A pilot study of IL-1 inhibition by anakinra in acute gout Arthritis Res Ther 2007, 9:R28 1906806 17352828 10.1186/ar2143
88. Kok MR Baum BJ Tak PP Pillemer SR Use of localised gene transfer to develop new treatment strategies for the salivary component of Sjögren's syndrome Ann Rheum Dis 2003, 62:1038-1046 1754372 14583564 10.1136/ard.62.11.1038
89. Kok MR Yamano S Lodde BM Wang J Couwenhoven RI Yakar S Voutetakis A Leroith D Schmidt M Afione S Pillemer SR Tsutsui MT Tak PP Chiorini JA Baum BJ Local adeno-associated virus-mediated interleukin 10 gene transfer has disease-modifying effects in a murine model of Sjögren's syndrome Hum Gene Ther 2003, 14:1605-1618 10.1089/ 104303403322542257 14633403
90. Lodde BM Mineshiba F Wang J Cotrim AP Afione S Tak PP Baum BJ Effect of human vasoactive intestinal peptide gene transfer in a murine model of Sjögren's syndrome Ann Rheum Dis 2006, 65:195-200 10.1136/ ard.2005.038232 15975969 1798026
91. Voutetakis A Kok MR Zheng C Bossis I Wang J Cotrim AP Marracino N Goldsmith CM Chiorini JA Loh YP Nieman LK Baum BJ Reengineered salivary glands are stable endogenous bioreactors for systemic gene therapeutics Proc Natl Acad Sci USA 2004, 101:3053-3058 365743 14978265 10.1073/ pnas.0400136101
92. Raz E Dudler J Lotz M Baird SM Berry CC Eisenberg RA Carson DA Modulation of disease activity in murine systemic lupus erythematosus by cytokine gene delivery Lupus 1995, 4:286-292 10.1177/096120339500400409 8528225
93. Hagiwara E Okubo T Aoki I Ohno S Tsuji T Ihata A Ueda A Shirai A Okuda K Miyazaki J Ishigatsubo Y IL-12-encoding plasmid has a beneficial effect on spontaneous autoimmune disease in MRL/MP-lpr/lpr mice Cytokine 2000, 12:1035-1041 10.1006/cyto.1999.0662 10880249
94. Lawson BR Prud'homme GJ Chang Y Gardner HA Kuan J Kono DH Theofilopoulos AN Treatment of murine lupus with cDNA encoding IFN-gammaR/Fc J Clin Invest 2000, 106:207-215 314313 10903336 10.1172/JCI10167
95. Shimizu S Nakashima H Masutani K Inoue Y Miyake K Akahoshi M Tanaka Y Egashira K Hirakata H Otsuka T Harada M Antimonocyte chemoattractant protein-1 gene therapy attenuates nephritis in MRL/lpr mice Rheumatology (Oxford) 2004, 43:1121-1128 10.1093/rheumatology/keh277 15213333
96. Haviv YS Takayama K Nagi PA Tousson A Cook W Wang M Lam JT Naito S Lei X Carey DE Curiel DT Modulation of renal glomerular disease using remote delivery of adenoviral-encoded solubletype II TGF-beta receptor fusion molecule J Gene Med 2003, 5:839-851 10.1002/jgm.428 14533192
97. Takiguchi M Murakami M Nakagawa I Saito I Hashimoto A Uede T CTLA4IgG gene delivery prevents autoantibody production and lupus nephritis in MRL/lpr mice Life Sci 2000, 66:991-1001 10.1016/S0024-3205(99)00664-5 10724446
98. Ding H Wu X Wu J Yagita H He Y Zhang J Ren J Gao W Delivering PD-1 inhibitory signal concomitant with blocking ICOS co-stimulation suppresses lupus-like syndrome in autoimmune BXSB mice Clin Immunol 2006, 118:258-267 10.1016/j.clim.2005.10.017 16386962
99. Liu W Szalai A Zhao L Liu D Martin F Kimberly RP Zhou T Carter RH Control of spontaneous B lymphocyte autoimmunity with adenovirus-encoded soluble TACI Arthritis Rheum 2004, 50:1884-1896 10.1002/art.20290 15188365
100. Ye X Zhu T Bastacky S McHale T Li J Xiao X Prevention and reversal of lupus in NZB/NZW mice by costimulatory blockade with adeno-associated virus-mediated gene transfer Arthritis Rheum 2005, 52:3975-3986 10.1002/ art.21417 16329128
101. Kyttaris VC Sfikakis PP Juang YT Tsokos GC Gene therapy in systemic lupus erythematosus Curr Gene Ther 2005, 5:677-684 10.2174/ 156652305774964703 16457656
102. Blank M Krause I Wildbaum G Karin N Shoenfeld Y TNFalpha DNA vaccination prevents clinical manifestations of experimental antiphospholipid syndrome Lupus 2003, 12:546-549 10.1191/0961203303lu399oa 12892396
103. Otani K Nita I Macaulay W Georgescu HI Robbins PD Evans CH Suppression of antigen-induced arthritis in rabbits by ex vivo gene therapy J Immunol 1996, 156:3558-3562 8617986
104. Makarov SS Olsen JC Johnston WN Anderle SK Brown RR Baldwin AS Jr Haskill JS Schwab JH Suppression of experimental arthritis by gene transfer of interleukin 1 receptor antagonist cDNA Proc Natl Acad Sci USA 1996, 93:402-406 40246 8552648 10.1073/pnas.93.1.402
105. Evans CH Arthritis gene therapy at an inflection point Future Rheumatol 2008, 3:207-210 10.2217/17460816.3.3.207
106. Evans CH Ghivizzani SC Kang R Muzzonigro T Wasko MC Herndon JH Robbins PD Gene therapy for rheumatic diseases Arthritis Rheum 1999, 42:1-16 10.1002/1529-0131(199901)42:1<1::AID-ANR1>3.0.CO;2-4 9920008